Declared Dividend • May 20
Dividend increased to €1.40 Dividend of €1.40 is 7.7% higher than last year. Ex-date: 10th June 2026 Payment date: 12th June 2026 Dividend yield will be 3.7%, which is higher than the industry average of 2.1%. Sustainability & Growth Dividend is covered by both earnings (65% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased by an average of 37% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 31% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Board Change • May 20
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. No experienced directors. 6 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. 공시 • Apr 28
Neurones S.A., Annual General Meeting, Jun 04, 2026 Neurones S.A., Annual General Meeting, Jun 04, 2026. Location: 205 avenue georges clemenceau, nanterre France Board Change • Dec 30
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. No experienced directors. 6 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. 공시 • Nov 08
Neurones S.A. Provides Earnings Guidance for the Full Year 2025 Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% . 공시 • Nov 05
Neurones S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026 Neurones S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026 공시 • Apr 29
Neurones S.A., Annual General Meeting, Jun 05, 2025 Neurones S.A., Annual General Meeting, Jun 05, 2025. Location: 205 avenue georges clemenceau, nanterre France 공시 • Mar 06
Neurones S.A. Proposes Dividend for 2024 Neurones S.A. announced that att the Shareholders' Meeting on June 5, 2025, the Board will suggest paying a dividend of €1.3 per share for 2024 (compared with €1.2 the previous year). 공시 • May 17
Neurones S.A. Provides Earnings Guidance for the Year 2024 Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%. Buy Or Sell Opportunity • Apr 26
Now 20% undervalued The stock has been flat over the last 90 days, currently trading at €44.80. The fair value is estimated to be €56.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year. Buy Or Sell Opportunity • Apr 11
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 9.5% to €46.60. The fair value is estimated to be €38.61, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year. Board Change • Mar 26
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. 공시 • Nov 28
Neurones S.A. to Report First Half, 2024 Results on Sep 11, 2024 Neurones S.A. announced that they will report first half, 2024 results on Sep 11, 2024